Sandra Gellhaar

Publications
CV
Public outreach and news

Articles

Article: NEUROSCIENCE LETTERS. 2022;784:136767
Glucocerebrosidase variant T369M is not a risk factor for Parkinsons disease in Sweden
Ran C; Brodin L; Gellhaar S; Westerlund M; Fardell C; Nissbrandt H; Soderkvist P; Sydow O; Markaki I; Hertz E; Wirdefeldt K; Svenningsson P
Article: CELL AND TISSUE RESEARCH. 2017;369(3):445-454
Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease
Gellhaar S; Sunnemark D; Eriksson H; Olson L; Galter D
Article: NEUROBIOLOGY OF AGING. 2016;45:212.e5-212.e11
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
Ran C; Brodin L; Forsgren L; Westerlund M; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Soderkvist P; Puschmann A; Ygland E; Olson L; Willows T; Johansson A; Sydow O; Wirdefeldt K; Galter D; Svenningsson P; Belin AC
Article: GENES BRAIN AND BEHAVIOR. 2015;14(3):260-270
Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice
Gellhaar S; Marcellino D; Abrams MB; Galter D
Article: NEUROBIOLOGY OF DISEASE. 2014;71:345-358
Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
Tsika E; Kannan M; Foo CS-Y; Dikeman D; Glauser L; Gellhaar S; Gaiter D; Knott GW; Dawson TM; Dawson VL; Moore DJ
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2013;1832(12):2352-2367
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4
Haebig K; Gellhaar S; Heim B; Djuric V; Giesert F; Wurst W; Walter C; Hentrich T; Riess O; Bonin M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(19):7916-7921
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models
Hedskog L; Pinho CM; Filadi R; Ronnback A; Hertwig L; Wiehager B; Larssen P; Gellhaar S; Sandebring A; Westerlund M; Graff C; Winblad B; Galter D; Behbahani H; Pizzo P; Glaser E; Ankarcrona M
Article: HUMAN MOLECULAR GENETICS. 2012;21(11):2420-2431
Neurodegenerative phenotypes in an A53T-synuclein transgenic mouse model are independent of LRRK2
Daher JPL; Pletnikova O; Biskup S; Musso A; Gellhaar S; Galter D; Troncoso JC; Lee MK; Dawson TM; Dawson VL; Moore DJ
Article: BEHAVIOURAL BRAIN RESEARCH. 2012;227(1):252-257
Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease
Anvret A; Ran C; Westerlund M; Gellhaar S; Lindqvist E; Pernold K; Lundstromer K; Duester G; Felder MR; Galter D; Belin AC
Article: FASEB JOURNAL. 2011;25(4):1333-1344
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease
Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Baeckman CM; Larsson N-G; Olson L; Gellhaar S; Galter D; Lupica CR
Article: FASEB JOURNAL. 2011;25(4):1345-1352
Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease
Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D

All other publications

Corrigendum: GENES BRAIN AND BEHAVIOR. 2015;14(5):442
Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice (vol 14, pg 260, 2015)
Gellhaar S; Marcellino D; Abrams MB; Galter D
Thesis / dissertation: 2015
Neurodegenerative diseases studied in human brain and rodent models
Gellhaar, Sandra
Conference publication: MOVEMENT DISORDERS. 2014;29:S60
Glucocerebrosidase (GBA) mutations in Parkinson's disease in Sweden and tissue expression of GBA mRNA
Ran C; Westerlund MO; Ramezani M; Gellhaar S; Xiang F; Fardell C; Nissbrandt H; Soderkvist P; Willows T; Willows T; Johansson AC; Wirdefeldt K; Sydow O; Olson L; Galter D; Belin AC

Employments

Coordinator, Central Administration, Karolinska Institutet, 2025-
Coordinator, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2025-2025
Research Coordinator, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2024-2024
Laboratory Manager, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2020-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of neuroscience, Karolinska Institutet, 2015

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI